Tag:

Germany

Latest Headlines

Latest Headlines

Cost watchdogs demand efficacy data on new Bayer cancer drugs

German pharma giant Bayer got back-to-back bad news on two of its newest drugs, from two different countries, no less.

The color purple knocks back Novartis' Advair rival in Germany

GlaxoSmithKline's asthma behemoth Advair may be losing ground in Europe, but a legal win may stop some of the bleeding--at least in Germany. The British pharma giant has obtained a preliminary injunction there to stop Novartis' Sandoz from hawking its generic, AirFluSal Forspiro, thanks to the inhaler's purple color.

Bayer expands German plants as it preps for new hemophilia treatments

The German drugmaker is feeling certain enough about a couple of potential hemophilia hits in its pipeline that it will spend nearly $700 million on new facilities in Germany that it says will add 500 jobs in its home country.

German billionaires back $76M gamble on Glycotope's drug trials

A pair of billionaire brothers helped Glycotope round up $76 million in venture cash to pay for Phase IIb trials of a pair of cancer drugs as well as a late-stage effort for a fertility therapy.

German med schools perfectly OK with pharma-rep visits and gifts

German med school deans aren't too concerned with pharma reps swaying their students' future prescription habits, according to a recent survey. 

German lawmakers drag pricing freeze out to 2017

The German government has decided to extend a drug-pricing freeze through 2017.

PPD partners up to give Germany a starring role in clinical trials

PPD has signed a deal with a German hospital to help bring more clinical trials to the country, agreeing to lend its global reach and help lure drug developers.

Germany may publicize its drug discounts, putting fear into Big Pharma's heart

Germany isn't the most popular market among drugmakers these days, thanks to strict pricing policies that have put a hurt on sales. Now, a proposed law could see the country fall further out of pharma's favor--and compromise the industry's international pricing power.

UPDATED: GSK warns of a possible global shortage of chickenpox vaccines

It turns out that Germany will not be the only country facing a shortage of GlaxoSmithKline's chickenpox vaccines. While healthcare providers there have already been given a heads up to prepare for rationing, the company says deliveries worldwide will be affected.

Bayer's hot-selling Eylea runs into a roadblock in its home market

Sales of Bayer's Eylea have taken off since the EU greenlighted the eye drug in late in 2012. But now, Germany's cost watchdog has thrown up a roadblock for the second time. Thursday, the German Institute for Quality and Efficiency in Health Care (IQWiG) said it was unable to assess whether Eylea provided an advantage over its rival, Novartis' Lucentis--an opinion that could hurt sales for Bayer on its home turf.